Literature DB >> 15807990

Metabolism of pantoprazole involving conjugation with glutathione in rats.

Dafang Zhong1, Zhiyong Xie, Xiaoyan Chen.   

Abstract

We have investigated the metabolism of pantoprazole and have provided an explanation for the formation mechanism of its metabolites. Metabolites found in the urine of rats after oral administration of pantoprazole sodium (25 mg kg(-1)) were analysed by liquid chromatography/ion trap mass spectrometry (LC/MS(n)). The N -acetylcysteine derivatives of benzimidazole (M1) and pyridine (M2), four pyridine-related metabolites (M3-M6), and three benzimidazole-related metabolites (M7-M9) were found, none of which had been reported previously. Five of the metabolites (M1, M2, M3, M7, and M8) were isolated from the urine of rats after oral administration of pantoprazole sodium by semipreparative HPLC. Structures of these metabolites were identified by a combination analysis of LC/MS(n) and (1)H NMR spectra. Structures of the remaining four metabolites (M4, M5, M6, and M9) were tentatively assigned through LC/MS(n). The metabolites M2, M3, M4, M5 and M6 and the other metabolites (M1, M7, M8, and M9) reflected the fate of the pyridine moiety and the benzimidazole moiety, respectively. The proposed formation route of M3-M6 was via initial reduction to mercaptopyridine followed by S-methylation, O-demethylation, and S-oxidation to the corresponding sulfoxide or sulfone. Meanwhile, M8 and M9 were formed via initial reduction to the 5-difluoromethoxy-1H benzoimidazole-2-thiol (M7) followed by hydroxylation and S-methylation. The metabolism of pantoprazole included an attack by glutathione on the benzimidazole-2-carbon and pyridine-7'-carbon. It is an important metabolic pathway of pantoprazole in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807990     DOI: 10.1211/0022357055669

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Pharmacokinetic differences between pantoprazole enantiomers in rats.

Authors:  Zhiyong Xie; Yini Zhang; Haiyan Xu; Dafang Zhong
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

2.  Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H+/K+-ATPase Inhibitor.

Authors:  Guiqiu Zhang; Kaijing Guo; Pengfei Wang; Yingbo Shan; Chen Ma
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

3.  Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration.

Authors:  Jeff D Olivarez; Amanda J Kreuder; Dane M Tatarniuk; Larry W Wulf; Katarzyna A Dembek; Jonathan P Mochel; Joe S Smith
Journal:  Front Vet Sci       Date:  2020-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.